Levonorgestrel Intrauterine System Mirena: An Update

Maruf Siddiqui, Fawzia Hossain, Lailaa Banu
In: Bangladesh Journal of Obstetrics & Gynaecology · 1970 · vol. 23(1) , pp. 25–31 · doi:10.3329/bjog.v23i1.3054 · W2037344569
article OA: diamond CC0
🔓 Open OA copy Full text JSON View on OpenAlex View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-08-07 ⓘ

This review explores the levonorgestrel intrauterine system Mirena's use for treating menorrhagia compared to other methods, based on recent trials.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-09-03 · read from full text ⓘ

This review article examines the non-contraceptive benefits of the levonorgestrel-releasing intrauterine system, Mirena, focusing on its efficacy in treating menorrhagia relative to other available methods based on recent clinical trials. The authors highlight that beyond reliable contraception, the device is widely indicated for managing dysmenorrhea, premenstrual symptoms, fibroids, and hormone replacement therapy. The text explicitly lists adenomyosis and endometriosis among the conditions treated by this hormonal IUD. Relevance to endometriosis: listed as one indication for GnRH antagonists, though the paper's main focus is uterine fibroids.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Mirena is a levonorgestrel-releasing intrauterine system. Apart from being a reliable contraception, Mirena is now widely indicated for its non contraceptive benefits which include treatment of menorrhagia, dysmenorrhoea, premenstrual symptoms, fibroids, adenomyosis, endometriosis etc. It is now used even for hormone replacement therapy. This review article tries to explore different aspects of Mirena for treatment of menorrhagia compared to other available methods based on recent trials. doi: 10.3329/bjog.v23i1.3054 Bangladesh J Obstet Gynaecol, 2008; Vol. 23(1) : 25-31
Full text 663 characters · extracted from oa-doi-fallback · click to expand
Levonorgestrel Intrauterine System Mirena: An Update Keywords: MirenaAbstract Mirena is a levonorgestrel-releasing intrauterine system. Apart from being a reliable contraception, Mirena is now widely indicated for its non contraceptive benefits which include treatment of menorrhagia, dysmenorrhoea, premenstrual symptoms, fibroids, adenomyosis, endometriosis etc. It is now used even for hormone replacement therapy. This review article tries to explore different aspects of Mirena for treatment of menorrhagia compared to other available methods based on recent trials. doi: 10.3329/bjog.v23i1.3054 Bangladesh J Obstet Gynaecol, 2008; Vol. 23(1) : 25-31 408 314

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosisadenomyosisdysmenorrhea

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (35)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK